Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy

Yurnadi H. Midoen, Dwi A. Suryandari, Luluk Yunaini, Raden Susworo, Elza I. Auerkari, Hans Joachim Freisleben

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences